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Abstract
Background: Anxiety is a common mental health problem seen in primary care. However, its management in
clinical practice varies greatly. Clinical practice guidelines (CPGs) have the potential to reduce variations and
improve the care received by patients by promoting interventions of proven benefit. However, uptake and
adherence to their recommendations can be low.
Method/design: This study involves a community based on cluster randomized trial in primary healthcare centres
in the Madrid Region (Spain). The project aims to determine whether the use of implementation strategy
(including training session, information, opinion leader, reminders, audit, and feed-back) of CPG for patients with
anxiety disorders in primary care is more effective than usual diffusion.
The number of patients required is 296 (148 in each arm), all older than 18 years and diagnosed with generalized
anxiety disorder, panic disorder, and panic attacks by the Diagnostic and Statistical Manual of Mental Disorders-IV
(DSM-IV). They are chosen by consecutive sampling.
The main outcome variable is the change in two or more points into Goldberg anxiety scale at six and twelve
months. Secondary outcome variables include quality of life (EuroQol 5D), and degree of compliance with the CPG
recommendations on treatment, information, and referrals to mental health services. Main effectiveness will be
analyzed by comparing the patients percentage improvement on the Goldberg scale between the intervention
group and the control group. Logistic regression with random effects will be used to adjust for prognostic factors.
Confounding factors or factors that might alter the effect recorded will be taken into account in this analysis.
Discussion: There is a need to identify effective implementation strategies for CPG for the management of anxiety
disorders present in primary care. Ensuring the appropriate uptake of guideline recommendations can reduce
clinical variation and improve the care patients receive.
Trial registration: ISRCTN: ISRCTN83365316
Background
Normal and pathological anxiety
Anxiety is a common mental health problem seen in
primary care. Anxiety can be defined as an anticipation
of future harm or misfortune, accompanied by a feeling
of unpleasantness and/or somatic symptoms of tension.
This feeling is normal in the face of certain day-to-day
stressing situations. When it exceeds a certain intensity
or overwhelms a person’s adaptive capacity, anxiety
becomes pathological. Anxiety disorders are a group of
illnesses characterized by the presence of worry, excess
of fear or dread, tension, or activation that causes a
notable uneasiness or a clinically significant deteriora-
tion of an individual’s activity [1].
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known, but biological factors, as well as environmental
and psychosocial ones, are involved [2-4]. Some authors
say that it is the interaction of multiple determining fac-
tors that favours the appearance of these anxiety disor-
ders [5]. In addition, co-morbidity with other mental
disorders, such as mood disorders, is very common
[3-6].
T h ep r o p e rd i a g n o s i s ,t r e a t m e n t ,a n d ,i nt h o s ec a s e s
where necessary, appropriate referral of anxiety disor-
ders to mental health services, is fundamental for effec-
tive clinical management [7,8].
Anxiety as a health problem
The prevalence of anxiety disorders varies depending on
different epidemiological studies, with prevalence-year
and prevalence-life being set at between 10.6% and
16.6% [9]. Data for Spain from the European Study of
the Epidemiology of Mental Disorders (ESEMeD) esti-
mate a prevalence-year of 5.1% [10,11]. Mental disorders
represent a burden for individuals, as well as for families
and the community. In the case of the community of
Madrid, neuropsychiatric illnesses are confirmed as the
first cause of adjusted years of life for incapacity [12].
According to the World Health Organization’sr e p o r t
on mental health, 20% of all patients attended by pri-
mary care professionals suffer one or more mental dis-
orders. This report recommends that management and
treatment be performed as far as possible in primary
care so as to facilitate access to services for the greatest
number of people possible [13].
Clinical practice guidelines (CPGs) as a tool for the
management of anxiety disorders in primary care
The diagnostic and therapeutic approach to these disor-
ders varies widely. Primary care professionals have dif-
ferent grades of training in the area of mental health, in
psychiatric interview skills, as well as in psychological
intervention techniques [14-16].
A study in the United States between 1985 and 1998
described an increase in the use of psychopharmaceuti-
cal medication in primary care visits (38.7% compared
with 54.6%) while, at the same time, it showed a con-
s t a n td r o pi nt h eu s eo fp s y c h ological interventions
(6.8% to 2%) in the treatment of anxiety disorders [17].
CPGs are a good tool to reduce this variability and
improve evidence informed in the clinical decision-mak-
ing. In Spain, the Ministry of Health and Social Policy
has put into effect the ‘Guiasalud’ project [18] to draft
CPGs. In the framework of this project, the Clinical
Practice Guideline for the Approach to Anxiety Disorders
in Primary Care has been drafted in coordination with
the Technologies Assessment Unit of the Agencia Lain
Entralgo [19].
The scope of the CPG covers the diagnosis and man-
agement of adult patients with generalized anxiety disor-
ders (GAD) and panic disorder (PD), with or without
agoraphobia, in the context of primary care.
Two aspects of this CPG development are worth not-
ing. The first is the involvement of patients with anxiety
disorders in all phases of the development process. The
second is that the CPG includes interventions that can
be carried out by the various professionals working in
primary care. These interventions are carried out at the
p r i m a r yh e a l t h c a r ec e n t e r s ,m a i n l yb yn u r s i n ga n d / o r
social workers [19]. Likewise, it is worth noting the low
utilization of psychological interventions of proven effec-
tiveness [20]. Our group has carried out a study that
focuses on the evaluation of the effectiveness of the
intervention groups directed by nurses in patients with
anxiety in primary care [21].
The Goldberg Anxiety and Depression Scale (GADS)
has been included in the guideline to evaluate the
changes obtained by the various interventions and as a
way to provide key questions to guide the clinical inter-
view. This scale has been chosen because it is brief and
easy to manage and interpret [22-24]. The Spanish ver-
sion has demonstrated its reliability and validity within
the ambit of primary care, and it has the right sensitivity
(83.1%), specificity (81.8%), and positive predictive value
(95.3%) [25].
Strategies to implement CPGs
CPGs will only be useful for professionals and patients if
their recommendations are incorporated to regular clini-
cal practice. Achieving this is a complex process in
which several factors play a role [26,27].
To increase the use of the guideline, its distribution
and implementation strategy must be planned very care-
fully. As a first step, the identification oft h eb a r r i e r s
and facilitating factors, adapting all strategies to the set-
ting in which the CPGs will be used, is fundamental
[28-30].
Several CPGs implementation strategies have demon-
strated their effectiveness. Some authors group these
interventions depending on whom they are addressed
to: physicians and patients, communities or the general
population, or health centres and/or health systems [31].
The Cochrane EPOC (Effective Practice and Organiza-
tion of Care) group proposes to classify interventions
into four categories: professional interventions (such as
distribution of educational materials or educational
meetings); financial interventions (such as fee-for-service
or prospective payment); organisational interventions
(such as creation of clinical multidisciplinary teams) and
regulatory interventions (anyi n t e r v e n t i o nt h a ta i m st o
change health services delivery or costs by regulation or
law) [32].
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t i v e n e s sa n dc o s to fd i f f e r e n tclinical practice guideline
dissemination-implementation organizational strategies.
This study takes into account the impact on profes-
sionals as well as on patients. It includes 235 studies
(between 1966 and 1998) and 309 comparisons. Among
the results, it is worth noting that most implementation
strategies improved adherence to CPGs. Simple strate-
gies, such as reminders, increase adherence by 14.1%.
The distribution of educational materials improves this
by 8.1%. Educational programmes, almost always as
components of more complex interventions, improved
practice by 6%, and audits and feedback by 7%. The
complexity of the strategies and the mixture of interven-
tions did not improve results. In their conclusions, it is
noted that there is little evidence about which strategies
can be more effective in each situation. The authors
consider that there is a need to develop and validate
theoretical models for behavioural change, as well as to
investigate the efficiency of the strategies in the presence
of different barriers and factors that can modify
effectiveness.
We consider it fundamental to put into effect organi-
zational strategies that will enable us to use the guide-
line and apply its recommendations, as well as to
measure and evaluate the impact that implementation of
the CPGs will have on professionals modifying their
practices, and improving outcomes for patients [34,35].
There are two reasons for using cluster randomised
trials design: to evaluate the group effect of an interven-
tion; and to avoid ‘contamination’ across interventions
when trial participants are managed within the same
setting.
Main objective
The aim of the present work is to determine whether
the use of a CPG implementation strategy (including
training session, information, opinion leader, reminders,
audit, and feed-back) for patients with anxiety disorders
in primary care is more effective than usual diffusion in
improving the score of the Goldberg anxiety scale at six
and twelve months.
Secondary objectives
1. Evaluate the effectiveness of a CPG implementation
strategy for the management of patients with anxiety
disorders compared with the regular strategy, measured
as the degree of suitability of the treatments (psycholo-
gical, pharmacological, et al.) received by patients.
2. Evaluate the effectiveness of a CPG implementation
strategy for the management of patients with anxiety
disorders compared with the regular strategy, measured
as the percentage of patients who have received the
information proposed in the guideline (oral or written)
about their disorder.
3. Evaluate the effectiveness of a CPG implementation
strategy for the management of patients with anxiety
disorders compared with the regular strategy, measured
as the degree of suitability of referral to mental health
services, based criteria established in the guideline.
4. Describe the professionals’ opinion about the use-
fulness of the CPG.
5. Evaluate the effectiveness of a CPG implementation
strategy for the management of patients with anxiety
disorders compared with the regular strategy measured
as a change in the patient’s quality of life.
Methods/design
Design of the study
This study is a two-year community, parallel clinical
trial, randomised by clusters, that compares two differ-
ent CPG implementation strategies. The intervention
will be made on health professionals (physicians, nurses,
and social workers) of primary healthcare centres
(PHCC) in the region of Madrid, Spain. The randomiza-
tion units will be PHCCs (clusters). The units of analysis
are patients of health professionals (individual level) of
t h eP H C C sp a r t i c i p a t i n gi nt h es t u d y( a sac o n t r o lo r
intervention) according to the CONSORT checklist
(additional file 1).
Subjects of the study
Subjects older than 18 years of age, who visit primary
care because of symptoms compatible with anxiety dis-
orders at PHCCs in the region of Madrid, and those
who have been diagnosed with anxiety disorders accord-
ing to Statistical Manual of Mental Disorders-IV (DSM-
IV) criteria [1].
Inclusion criteria
Agree to participate in the study and written informed
consent.
Exclusion criteria
1. Subjects diagnosed with anxiety for post-traumatic
stress, acute stress disorders, anxiety disorders induced
by substances, organic anxiety disorders.
2. Subjects who cannot read or understand Spanish.
3. Subjects who will not reside in the basic area in the
year following their inclusion in the study.
4. Immobilized or institutionalized patients.
Sample size
Method of calculation
For an alpha of 0,05, a power of 80% and in order to
detect a decrease in the Goldberg Scale (two or more
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simple size required 206 patients (103 in each arm of
the study). Because randomisation was by cluster, the
sample size had to be larger than if simple randomisa-
tion had been performed, in order to take into account
the design effect (DE). The DE was calculated as follows:
DE = 1 + (nc -1 )*I C C( w h e r en c is the mean number
of individuals in the cluster, and ICC the intracluster
correlation coefficient) [36]. The ICC in the present
work was deemed to be 0.01. The mean cluster size was
assumed to be 20 patients. Given these assumptions,
and expecting a 20% loss rate, the final sample size
required was 296 patients (148 in each arm).
Randomisation
Unit of allocation
Allocation will be performed by clusters, the PHCC
being the randomisation unit. This will minimise possi-
ble contamination effects between professionals.
Sequence generation
The 16 PHCCs will be assigned to the intervention or
the control group following a simple, computer-gener-
ated random sequence (EPIDAT 3.1).
Concealment of allocation
R a n d o m i z a t i o nw i l lb ep e r f o r m e dc e n t r a l l yb ya
researcher not involved in the study, and who was blind
to the identity of the PHCCs.
Consecutive patients will be chosen to minimise the
risk of bias in their selection. During consultations,
patients will be informed about the study and asked
w h e t h e rt h e yw o u l dl i k et ot a k ep a r ti ni t .T h o s ew h o
accept will be asked to complete a signed consent form.
Checks will be made to ensure they met all inclusion
criteria, but no exclusion criterion.
Masking
In the study, the patients, the professionals implement-
ing the interventions, and those assessing the outcomes
will not be blinded to the assignment group. However,
analysis data will be performed by independent profes-
sionals blinded to the assignment group.
Intervention (see Table 1)
Control group
1. The CPGs will be searchable on the intranet corpora-
tive system.
2. Centralized area clinical session with a duration of
60 minutes, to which each one of the professionals from
each of the 16 health centres will be invited, and where
the CPGs will be presented.
Intervention group
The intervention, through the different strategies, has
been designed to allow professionals to understand the
guideline thoroughly, and also to implement its
recommendations.
1. The CPG will be searchable on the intranet cor-
porative system.
2. Centralized area clinical session with a duration of
60 minutes, to which each one of the professionals from
each of the 16 PHCCs will be invited and where the
CPG will be presented.
3. Information: Presentation of CPG in the PHCCs.
4. Training: two sessions with a duration of 60 min-
utes, imparted at PHCCs by the researchers.
5. Information and training to physicians, nurses, and
social workers with the following contents:
a. Information and diagnosis: This would focus on
the questions in the guideline that approach the
definition of anxiety and its differentiation as a
symptom and as a disorder. It would approach the
semi-structured interview at the visit with an active
methodology (roll-playing, et al.).
b. Pharmacological treatment and algorithms.
c. Non-pharmacological treatment: Group techni-
ques (see table 2), bibliotherapy and medicinal herbs.
2. Opinion head/leader: a professional designated at
each centre (physician, nurse or social worker).
3. Structured training: Training of nurses and social
workers to carry out anxiety disorder groups of six to
eight sessions.
4. Reminders: Reminders will be sent in the form of
letters or electronic flashes or systems of alert about
publications.
5. Audit: The results will be audited and will be
returned to the PHCCs through the local leader.
Patient variables (individual level)
Variables to measure health outcomes
1. Degree of anxiety, measured by the Goldberg anxiety
subscale. The decrease in the score by two or more
points compared with baseline score will be evaluated at
six and twelve months.
2. Quality of life measured by means of the EuroQol
5D questionnaire. The quality of life will be evaluated at
baseline, six months and twelve months.
Clinical variables recorded to check the degree of
suitability of the guideline recommendations
Previous episodes and treatment, diagnosis and current
therapeutic plan, and reason for referral to mental health.
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Step 1 Centralized clinical session for the 16 PHCCs in which the GPC will be presented. Website ‘Guiasalud’.
Invitation to participate.
Step 2 Primary Healthcare Centre RANDOMIZATION
Step 3 Intervention group Control group
IMPLEMENTATION STRATEGIES:
- Information and training about diagnosis and therapeutic plan
- Election of opinion leader
- Information and training structured to create anxiety disorder groups
Regular care
Step 4 (after visit 2) IMPLEMENTATION STRATEGIES:
- Audit and feedback
- Reminders
Regular care
Step 5 (after visit 3) IMPLEMENTATION STRATEGIES:
- Audit and feedback
- Reminders
Regular care
Table 2 Group intervention in anxiety
First session
Presentation of the group
General introduction to program
Educational component:
￿ What is the response to anxiety?
￿ Why does it happen in daily life?
￿ Is recovery possible?
￿ What is the recovery process?
The role of lifestyle in the response to anxiety (Part 1):
￿ What do we do to take care of ourselves?
￿ How lifestyle influences.
￿ Introduction to relaxation and breathing.
Second session
Introduction, we clarify doubts.
The interpretation of body sensations. What is an anxiety crisis? Why does it appear?
Understand the role thoughts-behaviour-emotions play in the maintenance of the problem.
The role of lifestyle in the response to anxiety (Part 2):
￿ Physical exercise
￿ We learn to breath (control of breathing)
￿ Relaxation training
Third session
We review relaxation training execution and follow up with respect to exercise.
The role of lifestyle in the response to anxiety (Part 3):
￿ Eating/consumption toxics/stimulants
￿ Control of breathing
￿ Relaxation training
Fourth session
We review relaxation training execution and follow up with respect to exercise.
The role of lifestyle in the response to anxiety (Part 4):
￿ Pace activity/rest (sleep)
￿ Control of breathing
￿ Relaxation training
Fifth session
We review control of breathing and relaxation training execution.
Sixth session
We review control of breathing and relaxation training execution.
Using what we learned to face future changes: integrating vision to remember what we learned.
Depending on availability, the group intervention can be extended to eight sessions.
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Age, gender, nationality, time of residence in Spain, and
employment status.
Variables recorded for family physicians (cluster level)
Age, gender, years of professional activity, training in
interview skills, training in psychological intervention
techniques, average number of patients attended in
three months, and evaluation about usefulness of the
guide and modification of its clinical practice.
Data collection method
Professionals
Data will be collected by telephone interview by a mem-
ber of the research team before randomisation. All data
will be collected except the number of patients visited,
which will be taken from the health information system.
Opinion will be collected at the end of the study.
Patients
The clinical interview will be used and the data will be
recorded in an electronic data collection log especially
designed for this study. The different variables will be
collected over four follow-up visits: baseline, three, six,
and twelve months. The Figure 1 shows the flowchart of
the study.
Statistical analysis
This will be based on the principle of intention to treat.
The use of the design by clusters chosen will be taken
into account in all phases of data analysis, especially in
the calculation of the confidence intervals (CI) of the
estimates and in the hypothesis tests:
1. Descriptive analysis of each variable with its corre-
sponding CI at 95%. Tests for normality. Description of
losses and quitting.
2. Comparison of the group at the beginning of the
trial with regards to response variables, descriptive vari-
ables, and prediction factors. Bivariate statistical tests
will be used suitable to the type of variable (qualitative
or quantitative).
3. Analysis of primary outcome. There will be a com-
parison of the percentage of patients with a reduction
of two or more points on the Goldberg anxiety sub-
scale at six and twelve months from the intervention in
both groups by the chi-squared test, and the confi-
dence interval of the difference will be calculated. Con-
founding variables will be controlled with multivariate
analysis based on logistic regression with random
effects.
4. Analysis of secondary outcome. For each of the sec-
ondary response variables the results of the variables
will be compared based on the group assigned by calcu-
lating the difference in proportions of each variable.
Ethical considerations
The study protocol was approved by the Research Ethics
Committee on 29 April 2010 and met all good clinical
practice demands right. This study has been funded by
the Spanish Ministry of Science and Innovation via the
Instituto de Salud Carlos III (PI09/90304). The trial was
registered with Current Controlled Trials, number
ISRCTN83365316.
[http://www.controlled-trials.com/ISRCTN83365316]
Discussion
The proposed implementation strategy should have
impact at four levels: increasing the knowledge of clinical
physicians and patients; changing attitudes; changing the
habits and behaviour of professionals in their clinical prac-
tice, while taking into account the patient’s preferences, as
well as administrative and economic influences; and modi-
fying results, which means improving the quality of care
and, finally, the health of the population by following CPG
recommendations [37,38]. In this study, we will focus on
checking the degree of suitability of the guideline recom-
mendations (in terms of treatment, referral to mental
health services, and information to the patient) in the clin-
ical practice. We will also check if health outcomes (anxi-
ety and quality of life) are improving.
If the intervention proposed is effective, it could be
generalized to other common problems present in pri-
mary care. The findings of the study can also inform a
future updates of the guideline. The ‘Guiasalud’ project
includes a methodological manual for GPCs implemen-
tation [39]; the study outcomes may serve, moreover, to
evaluate this manual.
In addition, our project seeks to enhance the impor-
tance of multidisciplinary teams working in the design,
implantation and evaluation of CPGs.
As for the limitations of this study, the design selected
for this project is the best possible given the intervention,
while seeking to avoid possible contamination. Although
the number of clusters is enough for the randomization
to balance the potentially confounding factors among
themselves, the following must be taken into account:
1. Given the nature of the study, the intervention can-
not be masked.
2. There may be a classification bias, given the diffi-
culty professionals have for making specific diagnoses,
but this should be minimized by the information con-
tained in the guideline.
3. Patients will be enrolled in the study by their own
professionals. This increases variability in the approach,
which will be minimized, on the one hand, by the train-
ing of all participating professionals and, on the other
hand, by the protocolization of the research and the
implementation of the computer application of the data
collection log in the computer programme. Moreover,
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will increase applicability in regular practice.
4. Although losses are contemplated in the follow-up,
these are reduced in primary care because of the proxi-
mity of users to the system.
5. There may be a selection bias, because the selection
and inclusion of patients will take place after randomisa-
tion of clusters. In order to be able to evaluate this bias, the
information of those persons who decline to participate for
each intervention group will be collected and compared.
Figure 1 Flowchart.
Tello-Bernabé et al. Implementation Science 2011, 6:123
http://www.implementationscience.com/content/6/1/123
Page 7 of 9In summary, the main contribution of our project is
that it seeks to identify an effective strategy for imple-
menting a CPG for the management of a common
disorder present in primary care. Ensuring the appro-
priate uptake of guideline recommendations can
reduce clinical variation and improve the care patients
receive.
Additional material
Additional file 1: CONSORT checklist. Checklist of items to include
when reporting a cluster randomised trial.
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